tiprankstipranks
Trending News
More News >
TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
US Market
Advertisement

TransCode Therapeutics (RNAZ) Technical Analysis

Compare
432 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
2Neutral
15Bearish
Technical Analysis Consensus
Buy
5Bullish
2Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
TransCode Therapeutics’s (RNAZ) Moving Averages Convergence Divergence (MACD) indicator is -0.74, suggesting TransCode Therapeutics is a Buy.
TransCode Therapeutics’s (RNAZ) 20-Day exponential moving average is 11.45, while TransCode Therapeutics’s (RNAZ) share price is $9.43, making it a Sell.
TransCode Therapeutics’s (RNAZ) 50-Day exponential moving average is 11.77, while TransCode Therapeutics’s (RNAZ) share price is $9.43, making it a Sell.

TransCode Therapeutics (RNAZ) Pivot Points

Nov 09, 2025, 08:30 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
8.07
8.57
8.93
9.42
9.78
10.28
10.64
Fibonacci
8.57
8.89
9.10
9.42
9.75
9.95
10.28
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

TransCode Therapeutics (RNAZ) Moving Averages

Nov 09, 2025, 08:30 AM
Period
Simple
Exponential
MA5
9.66Sell
9.81Sell
MA10
10.82Sell
10.62Sell
MA20
12.43Sell
11.45Sell
MA50
11.70Sell
11.77Sell
MA100
10.76Sell
18.66Sell
MA200
39.39Sell
56.51Sell
TransCode Therapeutics’s (RNAZ) 10-Day exponential moving average is 10.62, while TransCode Therapeutics’s (RNAZ) share price is $9.43, making it a Sell.
TransCode Therapeutics’s (RNAZ) 100-Day exponential moving average is 18.66, while TransCode Therapeutics’s (RNAZ) share price is $9.43, making it a Sell.
TransCode Therapeutics’s (RNAZ) stock price is $9.43 and TransCode Therapeutics’s (RNAZ) 50-day simple moving average is 11.70, creating a Sell signal.
TransCode Therapeutics’s (RNAZ) stock price is $9.43 and TransCode Therapeutics’s (RNAZ) 100-day simple moving average is 10.76, creating a Sell signal.
TransCode Therapeutics’s (RNAZ) stock price is $9.43 and TransCode Therapeutics’s (RNAZ) 200-day simple moving average is 39.39, creating a Sell signal.

TransCode Therapeutics (RNAZ) Technical Indicators

Nov 09, 2025, 08:30 AM
Name
Value
Implied Action
RSI (14)
33.56
Neutral
STOCH (9,6)
6.19
Buy
STOCHRSI (14)
4.67
Buy
MACD (12,26)
-0.74
Buy
ADX (14)
28.85
Neutral
Williams %R
-90.85
Buy
CCI (14)
-131.10
Buy
ATR (14)
1.05
-
Ultimate Oscillator
24.67
Sell
ROC
-36.11
Sell
TransCode Therapeutics’s (RNAZ) Relative Strength Index (RSI) is 33.56, creating a Neutral signal.
TransCode Therapeutics’s (RNAZ) Trend Strength Indicator (ADX) is 28.85, creating a Neutral signal.
TransCode Therapeutics’s (RNAZ) Commodity Channel Index (CCI) is -131.10, creating a Buy signal.
TransCode Therapeutics’s (RNAZ) Price Rate of Change (ROC) is -36.11, creating a Sell signal.

FAQ

Is RNAZ a Buy, Hold, or Sell?
Based on RNAZ’s technical indicators, RNAZ is a Sell.
    What is RNAZ’s RSI (14)?
    RNAZ’s RSI (14) is 33.56, which suggests RNAZ is a Neutral.
      What is RNAZ’s MACD?
      RNAZ’s MACD is -0.74, which suggests RNAZ is a Buy.
        What is RNAZ’s 5-day moving average?
        RNAZ’s 5-day moving average is 9.66, which suggests RNAZ is a Sell.
          What is RNAZ’s 20-day moving average?
          RNAZ 20-day moving average is 12.43, which suggests RNAZ is a Sell.
            What is RNAZ’s 50-day moving average?
            RNAZ’s 50-day moving average is 11.70, which suggests RNAZ is a Sell.
              What is RNAZ’s 200-day moving average?
              RNAZ’s 200-day moving average is 39.39, which suggests RNAZ is a Sell.
                What is RNAZ’s Williams % R (14)?
                RNAZ’s Williams % R (14) is -90.85, which suggests RNAZ is a Buy.
                  What is RNAZ’s CCI (14)?
                  RNAZ’s CCI (14) is -131.10, which suggests RNAZ is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis